Figures computed from official regulatory filings — .
Analysttarget 58.8 USD (+1561%) · consensus 4.5/5 · 2 buy · 0 hold · 0 sell
Ownershipinsiders 5.73% · institutions 2.6% · short 3.2% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Autonomix Medical, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Smith Trent N. | Award | n/a (No price was disclosed in the filing) | SEC |
| KLEMP WALTER Vtrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Bisson Lori | Award | n/a (No price was disclosed in the filing) | SEC |
| Hauser Bradley | Award | n/a (No price was disclosed in the filing) | SEC |
| Smith Trent N. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Capelli Christopher | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Bisson Lori | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Smith Trent N. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| KLEMP WALTER Vtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Bisson Lori | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Hauser Bradley | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Robins David Andrew | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | First in 12mo | SEC |
| KLEMP WALTER Vtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Smith Trent N. | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Bisson Lori | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Hauser Bradley | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| BioStar Ventures III, L.P. | BuyD (derivative) | $32.6K | First in 12mo | SEC |